Stock Reports

Math over Myth
Math over Myth is your weekly guide to stocks and ETFs in the psychedelic sector, this week focusing on the...
Math over Myth is your weekly source for psychedelic stock updates, including Compass Pathways and Revive Therapeutics...
Math over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS, Cybin, GH Research, Mindset, Numinus,...
Get the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin Naturals, and Revive...
Track the monthly performance of the psychedelic stock sector with our Math over Myth Stock News Roundup...
Psychedelic stock MindMed enters free fall as news of a private equity offering of common stock spooks retail investors...
The psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow...
In the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers...
If you want to invest in psychedelic stocks, ignore the hype and look at the technicals. We take a deep...
Cathie Wood is buying up stocks from the most dubious actors in the psychedelic sector. Given ARK Invest’s subpar performance,...